MI Ying-chang, ZHAO Xing-li. Multicenter, Randomized, Phase Ⅲ Trial of Decitabine Versus of either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients with Newly Diagnosed Acute Myeloid Leukemia[J]. Journal of Evidence-Based Medicine, 2013, 13(5): 264-267. DOI: 10.3969/j.issn.1671-5144.2013.05.003
|
Citation:
|
MI Ying-chang, ZHAO Xing-li. Multicenter, Randomized, Phase Ⅲ Trial of Decitabine Versus of either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients with Newly Diagnosed Acute Myeloid Leukemia[J]. Journal of Evidence-Based Medicine, 2013, 13(5): 264-267. DOI: 10.3969/j.issn.1671-5144.2013.05.003
|
MI Ying-chang, ZHAO Xing-li. Multicenter, Randomized, Phase Ⅲ Trial of Decitabine Versus of either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients with Newly Diagnosed Acute Myeloid Leukemia[J]. Journal of Evidence-Based Medicine, 2013, 13(5): 264-267. DOI: 10.3969/j.issn.1671-5144.2013.05.003
|
Citation:
|
MI Ying-chang, ZHAO Xing-li. Multicenter, Randomized, Phase Ⅲ Trial of Decitabine Versus of either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients with Newly Diagnosed Acute Myeloid Leukemia[J]. Journal of Evidence-Based Medicine, 2013, 13(5): 264-267. DOI: 10.3969/j.issn.1671-5144.2013.05.003
|
DownLoad: